Overview:

This research employed a large number of primary and secondary sources. In order to determine the segmentation types, industry trends, major players, competitive landscape, important market dynamics, and major player strategies, the research process involved analyzing a variety of industry-affecting factors.

Growth Influencing Factors:

The process of administering a pharmaceutical drug to achieve the intended therapeutic effect in a safe manner is known as drug delivery. Technological advancements in drug delivery have several advantages, including patient compliance, convenience, and ease of use. In order to increase drug efficiency and suggest better patient compliance, drug developers are concentrating on appropriate delivery and packaging options.

Pharma and biopharma businesses are concentrating on research and development to create novel compounds for a range of therapeutic uses and drug delivery systems. The companies prioritize research and development in order to produce and market innovative and high-quality products. Biopharmaceutical companies have also increased their R&D spending over time.

However, in the upcoming years, it is anticipated that the risk of needlestick injuries and the increased pricing pressure will limit the market growth to some degree.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085

Revenue Growth Analysis:

The global pharmaceutical drug delivery market in terms of revenue was estimated to be worth $1,656.9 billion in 2021 and is poised to reach $2,206.5 billion by 2026, growing at a CAGR of 5.9% from 2021 to 2026.

The pharmaceutical drug delivery industry's largest share was accounted for by the infectious disease segment.

The pharmaceutical drug delivery market is divided into segments based on application, including cancer, autoimmune diseases, central nervous system disorders, diabetes, respiratory diseases, infectious diseases, cardiovascular diseases, and diabetes. The segment that dealt with infectious diseases held the biggest market share worldwide in 2020. This market segment's significant share can be ascribed to the rising incidence of infectious diseases worldwide, rising R&D costs for novel medications due to the COVID-19 pandemic, and the growing number of FDA approvals for these medications.

Geographical Growth Dynamics:

Among companies involved in the pharmaceutical drug delivery market, Asia Pacific is anticipated to have the highest compound annual growth rate.

Asia Pacific is anticipated to grow at the fastest rate among regional markets for pharmaceutical drug delivery during the forecast period. The APAC market is anticipated to grow during the forecast period due to a number of factors, including the rapidly aging population, the rising prevalence of chronic diseases, the rise in healthcare spending, the increased R&D activities carried out in this region, the expansion of technological collaborations for pharmaceutical drug delivery technologies, the favorable reimbursement policies, and the rise in disposable incomes in the emerging Asian economies, like China and India.

Global Key Players:

Major players in this market include Johnson & Johnson (US), Novartis International AG (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Pfizer Inc. (US), Bayer AG (Germany), Antares Pharma, Inc. (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), 3M (US), Merck & Co., Inc. (US), Sanofi (France), Amgen, Inc. (US), AbbVie Inc. (US), Genmab A/S (Denmark), Gilead Sciences, Inc. (US), Boehringer Ingelheim (Germany), AstraZeneca plc. (UK), Eli Lilly and Company (US), Teva Pharmaceuticals Industries Ltd. (Israel), Bristol-Myers Squibb (US), Gerresheimer AG (Germany), Boston Scientific Corporation (US), Nimbus Therapeutics (US), Kite Pharma (US), and IDEAYA Biosciences, Inc. (US).

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085

Recent Developments of Pharmaceutical Drug Delivery Industry:

# In July 2021, Johnson & Johnson received FDA approval for DARZALEX (daratumumab), a subcutaneous formulation that reduces the treatment time for multiple myeloma indications.

# In December 2020, Pfizer, Inc. received FDA approval for BRAFTOVI (encorafenib) plus combination with cetuximab for the treatment of patients with brafv600e-mutant metastatic colorectal cancer (CRC) who have undergone prior therapy.

# In November 2020, GlaxoSmithKline plc partnered with IDEAYA to enter the field of Synthetic Lethality, an emerging field in oncology; programs MAT2A, Pol Theta, and Werner Helicase programs, which are part of it, are projected to reach clinical trials in the next three years.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]